CVS’s Algal-900 DHA Supplement

In July 2018, a class-action lawsuit was filed against CVS for allegedly marketing the supplement Algal-900 DHA as being clinically shown to improve memory and cognitive function and claiming the product is capable of reducing errors by “50% or more” in an “episodic memory test” when, according to the plaintiffs, the product does not work as advertised and CVS does not have adequate scientific support to make such claims. (Ferguson et al v. CVS Pharmacy, Inc., Case NO. 18-cv-1529, S.D. Cal.)

To read about’s legal actions pertaining to this CVS supplement, click here and here.

For more of’s coverage of CVS, click here.

Print Friendly, PDF & Email

Tags: , ,

Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect’s opinion with respect to the lawsuits or disposition of the cases